secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0000950170-22-026632
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix appoints Dr. James Swift as CEO; Mark Ordan becomes Executive Chair
-----------------------------------------------------------------------------

- James D. Swift, M.D., named CEO effective Jan 1, 2023; succeeds Mark S. Ordan.
- Mark Ordan appointed Executive Chair of the Board; Guy Sansone becomes Lead Independent Director.
- Swift's base salary increased to $650,000; annual bonus opportunity set at 125% of base.
- Ordan to receive $60,000 monthly fee as Executive Chair through June 30, 2023.
- Swift, a physician and former COO, joined Pediatrix in 2009 through an acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/0000950170-22-026632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022026632/md-20221215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer